ID

45474

Beschreibung

Principal Investigator: E. Ann Coleman, University of Arkansas for Medical Sciences Little Rock, Arkansas, USA MeSH: Multiple Myeloma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000545 We hypothesized that genetic variability in the enzymes/proteins involved in drug metabolism, inflammation, and immune function is a major underlying contributor to mucositis incidence and progression and that, based on this variability we can identify variants that influence risk, and develop a mucositis progression prediction model that improves on existing models by incorporating genetic variability along with clinical factors. Using genome wide association study (GWAS) combined with a pathway candidate gene approach and a modified case-control study method, we investigated the hypothesis in a sample of 1092 patients who received a myeloablative dose of melphalan (MEL) followed by autologous hematopoietic stem cell (ASCT) transplantation as treatment for multiple myeloma and for whom banked blood stem cell samples and clinical data were available.

Link

dbGap study = phs000545

Stichworte

  1. 31.10.22 31.10.22 - Simon Heim
  2. 13.12.22 13.12.22 - Kristina Keller
Rechteinhaber

E. Ann Coleman, University of Arkansas for Medical Sciences Little Rock, Arkansas, USA

Hochgeladen am

13. Dezember 2022

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

dbGaP phs000545 Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors

Eligibility Criteria

Inclusion and exclusion criteria
Beschreibung

Inclusion and exclusion criteria

Inclusion criteria: Patients with newly diagnosed multiple myeloma who underwent their initial MEL-ASCT between 1990 and April 2009
Beschreibung

Inclusion criteria: Patients with newly diagnosed multiple myeloma who underwent their initial MEL-ASCT between 1990 and April 2009

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1518321
UMLS CUI [1,3]
C0026764
UMLS CUI [1,4]
C2193200
UMLS CUI [1,5]
C0872291
Cases were patients who developed grade 2-4 mucositis and controls were patients who developed grade 0-1 mucositis using Common Toxicity Criteria (CTCAE) version 4.
Beschreibung

Cases were patients who developed grade 2-4 mucositis and controls were patients who developed grade 0-1 mucositis using Common Toxicity Criteria (CTCAE) version 4.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1706256
UMLS CUI [1,3]
C0038362
UMLS CUI [1,4]
C0013221
UMLS CUI [1,5]
C0243161
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C0009932
UMLS CUI [2,3]
C0038362
UMLS CUI [2,4]
C0013221
UMLS CUI [2,5]
C0243161

Ähnliche Modelle

Eligibility Criteria

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion and exclusion criteria
Inclusion criteria: Patients with newly diagnosed multiple myeloma who underwent their initial MEL-ASCT between 1990 and April 2009
Item
Inclusion criteria: Patients with newly diagnosed multiple myeloma who underwent their initial MEL-ASCT between 1990 and April 2009
boolean
C1512693 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0026764 (UMLS CUI [1,3])
C2193200 (UMLS CUI [1,4])
C0872291 (UMLS CUI [1,5])
Cases were patients who developed grade 2-4 mucositis and controls were patients who developed grade 0-1 mucositis using Common Toxicity Criteria (CTCAE) version 4.
Item
Cases were patients who developed grade 2-4 mucositis and controls were patients who developed grade 0-1 mucositis using Common Toxicity Criteria (CTCAE) version 4.
boolean
C1512693 (UMLS CUI [1,1])
C1706256 (UMLS CUI [1,2])
C0038362 (UMLS CUI [1,3])
C0013221 (UMLS CUI [1,4])
C0243161 (UMLS CUI [1,5])
C1512693 (UMLS CUI [2,1])
C0009932 (UMLS CUI [2,2])
C0038362 (UMLS CUI [2,3])
C0013221 (UMLS CUI [2,4])
C0243161 (UMLS CUI [2,5])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video